Bivalirudin and Desmopressin Market Share

Regionally, the global bivalirudin and desmopressin market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. North America is likely to dominate majority revenue share by 2036, as coronary artery disease (CAD) prevalence among the population resulted in increasing percutaneous coronary intervention (PCI) procedures in the region. It was observed that nearly 960,000 percutaneous coronary intervention procedures are performed each year in the United States. Percutaneous coronary intervention (PCI) also known as angioplasty, is a procedure to open a blocked or narrowing artery. Moreover, increasing cases of cardiovascular diseases and heart diseases in the region are expected to drive bivalirudin and desmopressin market growth during the forecast period. For instance, there were approximately 695,000 deaths caused by heart disease in the United States in 2020.